Dubai
English
Request a call
Book
ARA-290 Pen
2 000 AED
Raw Material
USA
Country of Origin
UAE
Purity
99%
Description
ARA-290 is a selective non-erythropoietic peptide engineered to activate the EPOR–CD131 receptor complex, a key regulator of anti-inflammatory, neuroprotective, and reparative pathways — without stimulating erythropoiesis. Through this mechanism, the peptide promotes endothelial restoration, reduces neuroinflammation, enhances microcirculation, and supports the functional recovery of peripheral nerve fibers.
ARA-290 modulates immune mediator activity, protects tissues under metabolic and stress-related load, and accelerates cellular repair. Clinical data indicate that ARA-290 may reduce neuropathic pain by 30–40%, improve tissue sensitivity, and increase nerve-conduction velocity, making it a valuable component of modern neuroregenerative programs. The pen format ensures precise delivery and stable bioavailability in protocols targeting nerve recovery, inflammation control, and endothelial protection.
• improves microcirculation and restores endothelial function
• decreases neuropathic pain and enhances tissue sensitivity
• supports peripheral nerve regeneration
• reduces oxidative stress and cellular injury
• improves nerve-conduction speed and accelerates functional recovery
• suitable for patients with neuropathic symptoms of various origins
• provides a consistent and predictable therapeutic response
• safe profile: no impact on erythropoiesis, hormones, or stimulation pathways
• combines effectively with MOTS-c, NAD+, FST, and neuroprotective protocols
ARA-290 Pen is ideal for individuals requiring nervous-system support, inflammation reduction, improved microcirculation, and restoration of sensory function. It is used in neuroprotection programs, recovery protocols following nerve strain or injury, peripheral conduction-support schemes, and strategies for managing neuropathic discomfort. The format helps accelerate tissue recovery, reduce pain, and enhance overall quality of life.
ARA-290 modulates immune mediator activity, protects tissues under metabolic and stress-related load, and accelerates cellular repair. Clinical data indicate that ARA-290 may reduce neuropathic pain by 30–40%, improve tissue sensitivity, and increase nerve-conduction velocity, making it a valuable component of modern neuroregenerative programs. The pen format ensures precise delivery and stable bioavailability in protocols targeting nerve recovery, inflammation control, and endothelial protection.
Key Properties & Effects of ARA-290
• reduces peripheral neuroinflammation by activating EPOR–CD131• improves microcirculation and restores endothelial function
• decreases neuropathic pain and enhances tissue sensitivity
• supports peripheral nerve regeneration
• reduces oxidative stress and cellular injury
• improves nerve-conduction speed and accelerates functional recovery
Why Choose ARA-290
• acts on core reparative and anti-inflammatory pathways• suitable for patients with neuropathic symptoms of various origins
• provides a consistent and predictable therapeutic response
• safe profile: no impact on erythropoiesis, hormones, or stimulation pathways
• combines effectively with MOTS-c, NAD+, FST, and neuroprotective protocols
ARA-290 Pen is ideal for individuals requiring nervous-system support, inflammation reduction, improved microcirculation, and restoration of sensory function. It is used in neuroprotection programs, recovery protocols following nerve strain or injury, peripheral conduction-support schemes, and strategies for managing neuropathic discomfort. The format helps accelerate tissue recovery, reduce pain, and enhance overall quality of life.
Other peptides
Fill out the form to book your consultation.
Your personal manager will contact you within 10 minutes and arrange a convenient time for your visit.
